| Emphasys Medical was founded with the charter of developing therapies to improve the quality of life for patients living with Chronic Obstructive Pulmonary Disease (COPD).
COPD is a group of lung diseases that afflict over 20 million Americans. These patients have been diagnosed with emphysema, chronic bronchitis, and/or asthma. Emphasys is currently focused on treating emphysema, which is characterized by the gradual, irreversible breakdown of lung tissue and loss of elasticity within the lungs. This breakdown dramatically reduces the ability of the lung to expel air. As the disease advances, the damaged, inelastic areas of the lung progressively expand within the chest cavity, leaving the patient constantly feeling out of breath since there is insufficient room available for the lung to function normally. |
